Increased faecal calprotectin predicts recurrence of colonic diverticulitis

International Journal of Colorectal Disease

Volumn 29, Issue 8, 2014, Pages 931-935

  Tursi, Antonio ^a   Elisei, Walter ^b   Picchio, Marcello ^c   Brandimarte, Giovanni ^d  

^a ASL BAT   (Italy)

^b ASL RMH   (Italy)

^c Hospital P Colombo   (Italy)

^d Cristo Re Hospital   (Italy)

Author keywords

Diverticulitis; Faecal calprotectin; Follow up; Recurrence

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; CEPHALOSPORIN; MESALAZINE; METRONIDAZOLE; RIFAXIMIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLON DIVERTICULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FECES CULTURE; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTOSIS; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REMISSION; TREATMENT DURATION; VERY ELDERLY; CHEMISTRY; FECES; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED;

AGED; AGED, 80 AND OVER; DIVERTICULITIS, COLONIC; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; RECURRENCE;

EID: 84904665729     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-014-1884-0     Document Type: Article

References (30)

1. Sheth AA, Longo W, Floch MH (2008) Diverticular disease and diverticulitis. Am J Gastroenterol 103:1550-1556 (Pubitemid 351813921)
2. Tursi A (2007) New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 8:299-307
3. Tursi A, Brandimarte G, Giorgetti G, Elisei W, Maiorano M, Aiello F (2008) The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci 53:2474-2479
4. Etzioni DA, Chiu VY, Cannom RR, Burchette RJ, Haigh PI, Abbas MA (2010) Outpatient treatment of acute diverticulitis: rates and predictors of failure. Dis Colon Rectum 53:861-865
5. Evans J, Kozol R, Frederick W, Voytavich A, Pennoyer W, Lukianoff A, Lardner J (2008) Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis? J Gastrointest Surg 12:577-582
6. Strate LL, Liu YL, Aldoori WH, Syngal S, Giovannucci EL (2009) Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 136:115-122
7. Tursi A, Elisei W, Giorgetti GM, Inchingolo CD, Nenna R, Picchio M, Brandimarte G (2013) Detection of endoscopic and histological inflammation after an attack of colonic diverticulitis is associated with higher diverticulitis recurrence. J Gastrointest Liver Dis 22:13-19
8. Bischoff SC, Grabowsky J, Manns MP (1997) Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 42:394-403 (Pubitemid 27112989)
9. Poullis A, Foster R, Mendall MA, Fagerhol MK (2003) Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 18:756-762 (Pubitemid 36936565)
10. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK (2001) Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 70:130-134 (Pubitemid 32613672)
11. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793-798
12. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF et al (1997) Functional and clinical aspects of the myelomonocytic protein calprotectin. J Clin Pathol Mol Pathol 50:113-123 (Pubitemid 27454995)
13. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15-22 (Pubitemid 30452574)
14. Costa F, Mumolo MG, Ceccarelli L et al (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54:364-368 (Pubitemid 40299092)
15. D'Inca R, Dal Pont E, Di Leo V et al (2008) Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 103:2007-2014
16. Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S (2008) Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis 14:669-673 (Pubitemid 351742984)
17. Gisbert JP, Bermejo F, Perez-Calle JL et al (2009) Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 15:1190-1198
18. Garcia-Sanchez V, Iglesias-Flores E, Gonzalez R et al (2010) Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J Crohns Colitis 4:144-152
19. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F (2009) Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 24:49-55
20. Kaiser AM, Jiang JK, Lake JP et al (2005) The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 100:910-917 (Pubitemid 40592387)
21. Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N (2008) Fecal calprotectin: assessment of a rapid test. Scand J Clin Lab Invest 68:343-347 (Pubitemid 351962410)
22. Sandler RS, Everhart JE, Donowitz M et al (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500-1511 (Pubitemid 34465190)
23. Ambrosetti P, Becker C, Terrier F (2002) Colonic diverticulitis: impact of imaging on surgical management - a prospective study of 542 patients. Eur Radiol 12:1145-1149 (Pubitemid 36940184)
24. Allez M, Lémann M (2010) Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol 16:2626-2632
25. Parente F, Molteni M, Marino B et al (2010) Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: A prospective study. Am J Gastroenterol 105:1150-1157
26. Rutgeerts P, Vermeire S, Van Assche G (2008) What is the role of endoscopy in predicting Crohn's disease relapse or course? Inflamm Bowel Dis 14(Suppl 2):S183-S184
27. Bitton A, Peppercorn MA, Antonioli DA et al (2001) Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120:13-20 (Pubitemid 32061864)
28. Ruffolo C, Scarpa M, Faggian D et al (2010) Subclinical intestinal inflammation in patients with Crohn's disease following bowel resection: a smoldering fire. J Gastrointest Surg 14:24-31
29. Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F (2010) Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. J Clin Gastroenterol 44:702-706
30. Burri E, Beglinger C (2012) Faecal calprotectin - a useful too in the management of inflammatory bowel disease. Swiss Med Wkly 142:w13557